PAVmed Inc.

medical devices

About

PAVmed Inc. is a medical device company based in New York City, founded in 2014. The company specializes in acquiring, developing, and commercializing innovative, minimally invasive medical technologies that meet unmet clinical needs in the U.S. healthcare market. PAVmed's product portfolio includes a range of devices such as CarpX for carpal tunnel syndrome, the EsoCheck device for collecting esophageal cells, and the EsoGuard DNA assay for cancer detection. Other offerings include the EsoCure device for Barrett’s Esophagus treatment, the PortIO vascular access device, and the NextFlo infusion system. The company also features products like DisappEAR, NextCath, and Caldus, along with its life sciences initiatives through Lucid Diagnostics and Veris Health. The company focuses on early-stage medical device technologies, advancing them through clinical trials to improve patient outcomes and reduce healthcare costs. PAVmed serves patients with various conditions and healthcare providers, leveraging its expertise in medical device engineering and regulatory affairs.

Technologies

Outlook Amazon AWS Mobile Friendly Google Font API Piwik Google Tag Manager MemberClicks Remote AI

Keywords

cardiology orthopedics gastroenterology healthcare economics medical/dental instruments health care digital health medical technology medical device wireless communication sensors biotech innovation digital health connectivity molecular diagnostics personalized cancer care digital health platform medical device development healthcare digital transformation healthcare systems integration remote monitoring oncology services clinical trials esocheck device remote patient monitoring cancer prevention healthcare equipment and supplies esophageal precancer healthcare innovation early detection biologic sensor technology

Location

60 E 42nd St, New York, New York, United States, 10165-0001

Related Companies

Companies in the same industry